COVID-19 Causes Genetic Changes that Create Long-Haul COVID-19 Symptoms, Researchers Find
What Texas researchers found that changed baseline gene expression in airway cells.
COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
What Texas researchers found that changed baseline gene expression in airway cells.
Ultimately this research shows that the 6-foot rule should not be a core component of COVID-19 spread mitigation strategies, says MIT professor.
Clinical laboratories would test for COVID-19 antibodies in those with long-haul COVID-19 symptoms but are unsure if they were ever infected with SARS-CoV-2.
The recent research on Slovakia’s national testing program provides a potential model for containing infectious disease outbreaks.
Clinical laboratories should be aware of the potential for quantitative differences in COVID-19 antibody levels, as demand for antibody testing may increase.
As new vaccine breakthrough research continues, Virginia Tech and UVA virologists develop innovative COVID-19 vaccine production platform.
This complimentary program features leading clinical laboratory thought leaders James O. Westgard, PhD, Sten Westgard and The Dark Report founder Robert L. Michel, as they discuss how labs can navigate the risks and pitfalls of COVID-19 serology testing. Learn what you should look for to ensure that the tests will produce accurate, reproducible test results.
Laboratories and pathology groups are facing unprecedented clinical, operational, financial, and legal challenges due to COVID-19. The legislative and regulatory landscape is as constantly evolving as the strategies that must be implemented. Stream this 90-minute webinar on demand for free, including an interactive Q&A session, and gain valuable insights that will enable you to implement the legal, operational, and financial strategies to maximize your position in this unique and demanding environment.
How are other clinical laboratories successfully working their way through the COVID-19 outbreak? What are different health networks doing to provide SARS-CoV-2 tests? Does your lab have questions dealing with specimen collection, availability of testing components, the analytical or post-analytical testing phase, your community’s population health direction, dealing with continually evolving algorithms, or PPE and overall safety concerns? Stream this 60-minute webinar, including an interactive Q&A session, and hear the lessons learned by labs who are effectively handling the logistics of the COVID-19 pandemic.
What Texas researchers found that changed baseline gene expression in airway cells.
Ultimately this research shows that the 6-foot rule should not be a core component of COVID-19 spread mitigation strategies, says MIT professor.
Clinical laboratories would test for COVID-19 antibodies in those with long-haul COVID-19 symptoms but are unsure if they were ever infected with SARS-CoV-2.
The recent research on Slovakia’s national testing program provides a potential model for containing infectious disease outbreaks.
Clinical laboratories should be aware of the potential for quantitative differences in COVID-19 antibody levels, as demand for antibody testing may increase.
As new vaccine breakthrough research continues, Virginia Tech and UVA virologists develop innovative COVID-19 vaccine production platform.